Erratum: The antifungal and anti-pneumocystis activities of the novel compound A3IS (Mycosinate) (Antimicrobial Agents and Chemotherapy (2022) 66:8 (e00521-22) DOI: 10.1128/aac.00521-22)

Nathan P. Wiederhold; Thomas F. Patterson; Sandra Rebholz; James Brennan; Thomas Patton; John Barrett; Connell W.C. Boal; Monika Ehrensberger; Ryan Boyle; Melanie T. Cushion

doi:10.1128/aac.01475-22

Erratum: The antifungal and anti-pneumocystis activities of the novel compound A3IS (Mycosinate) (Antimicrobial Agents and Chemotherapy (2022) 66:8 (e00521-22) DOI: 10.1128/aac.00521-22)

Nathan P. Wiederhold, Thomas F. Patterson, Sandra Rebholz, James Brennan, Thomas Patton, John Barrett, Connell W.C. Boal, Monika Ehrensberger, Ryan Boyle, Melanie T. Cushion

Department of Life Sciences

Research output: Contribution to journal › Comment/debate

Abstract

Volume 66, no. 8, e00521-22, 2022, https://doi.org/10.1128/aac.00521-22. James Brennan, Thomas Patton, and John Barrett were not included in the byline in the original article. The byline and affiliation line should appear as shown above.

Original language	English
Journal	Antimicrobial Agents and Chemotherapy
Volume	67
Issue number	2
DOIs	https://doi.org/10.1128/aac.01475-22
Publication status	Published - Feb 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1128/aac.01475-22

Cite this

Wiederhold, N. P., Patterson, T. F., Rebholz, S., Brennan, J., Patton, T., Barrett, J., Boal, C. W. C., Ehrensberger, M., Boyle, R., & Cushion, M. T. (2023). Erratum: The antifungal and anti-pneumocystis activities of the novel compound A3IS (Mycosinate) (Antimicrobial Agents and Chemotherapy (2022) 66:8 (e00521-22) DOI: 10.1128/aac.00521-22). Antimicrobial Agents and Chemotherapy, 67(2). https://doi.org/10.1128/aac.01475-22

@article{e90cd544697f40e3a84de329d42598f5,

title = "Erratum: The antifungal and anti-pneumocystis activities of the novel compound A3IS (Mycosinate) (Antimicrobial Agents and Chemotherapy (2022) 66:8 (e00521-22) DOI: 10.1128/aac.00521-22)",

abstract = "Volume 66, no. 8, e00521-22, 2022, https://doi.org/10.1128/aac.00521-22. James Brennan, Thomas Patton, and John Barrett were not included in the byline in the original article. The byline and affiliation line should appear as shown above.",

author = "Wiederhold, {Nathan P.} and Patterson, {Thomas F.} and Sandra Rebholz and James Brennan and Thomas Patton and John Barrett and Boal, {Connell W.C.} and Monika Ehrensberger and Ryan Boyle and Cushion, {Melanie T.}",

year = "2023",

month = feb,

doi = "10.1128/aac.01475-22",

language = "English",

volume = "67",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

number = "2",

}

Wiederhold, NP, Patterson, TF, Rebholz, S, Brennan, J, Patton, T, Barrett, J, Boal, CWC, Ehrensberger, M, Boyle, R & Cushion, MT 2023, 'Erratum: The antifungal and anti-pneumocystis activities of the novel compound A3IS (Mycosinate) (Antimicrobial Agents and Chemotherapy (2022) 66:8 (e00521-22) DOI: 10.1128/aac.00521-22)', Antimicrobial Agents and Chemotherapy, vol. 67, no. 2. https://doi.org/10.1128/aac.01475-22

Erratum: The antifungal and anti-pneumocystis activities of the novel compound A3IS (Mycosinate) (Antimicrobial Agents and Chemotherapy (2022) 66:8 (e00521-22) DOI: 10.1128/aac.00521-22). / Wiederhold, Nathan P.; Patterson, Thomas F.; Rebholz, Sandra et al.
In: Antimicrobial Agents and Chemotherapy, Vol. 67, No. 2, 02.2023.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - The antifungal and anti-pneumocystis activities of the novel compound A3IS (Mycosinate) (Antimicrobial Agents and Chemotherapy (2022) 66:8 (e00521-22) DOI: 10.1128/aac.00521-22)

AU - Wiederhold, Nathan P.

AU - Patterson, Thomas F.

AU - Rebholz, Sandra

AU - Brennan, James

AU - Patton, Thomas

AU - Barrett, John

AU - Boal, Connell W.C.

AU - Ehrensberger, Monika

AU - Boyle, Ryan

AU - Cushion, Melanie T.

PY - 2023/2

Y1 - 2023/2

N2 - Volume 66, no. 8, e00521-22, 2022, https://doi.org/10.1128/aac.00521-22. James Brennan, Thomas Patton, and John Barrett were not included in the byline in the original article. The byline and affiliation line should appear as shown above.

AB - Volume 66, no. 8, e00521-22, 2022, https://doi.org/10.1128/aac.00521-22. James Brennan, Thomas Patton, and John Barrett were not included in the byline in the original article. The byline and affiliation line should appear as shown above.

UR - http://www.scopus.com/inward/record.url?scp=85148225270&partnerID=8YFLogxK

U2 - 10.1128/aac.01475-22

DO - 10.1128/aac.01475-22

M3 - Comment/debate

C2 - 36645296

AN - SCOPUS:85148225270

SN - 0066-4804

VL - 67

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

IS - 2

ER -

Erratum: The antifungal and anti-pneumocystis activities of the novel compound A3IS (Mycosinate) (Antimicrobial Agents and Chemotherapy (2022) 66:8 (e00521-22) DOI: 10.1128/aac.00521-22)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this